Risk factor analysis for a rapid progression of chronic kidney disease

Anne H S Vestergaard,Simon K Jensen,Uffe Heide-Jørgensen,Line E Frederiksen,Henrik Birn,Dorte E Jarbøl,Jens Søndergaard,Frederik Persson,Reimar W Thomsen,Christian F Christiansen
DOI: https://doi.org/10.1093/ndt/gfad271
IF: 7.1857
2024-01-02
Nephrology Dialysis Transplantation
Abstract:ABSTRACT Background Chronic kidney disease (CKD) is a growing global health concern. Identifying individuals in routine clinical care with new-onset CKD at high risk of rapid progression of the disease is imperative to guide allocation of prophylactic interventions, but community-based data are limited. We aimed to examine the risk of rapid progression, kidney failure, hospitalization and death among adults with incident CKD stage G3 and to clarify the association between predefined risk markers and rapid CKD progression. Methods Using plasma creatinine measurements for the entire Danish population from both hospitals and primary care, we conducted a nationwide, population-based cohort study, including adults in Denmark with incident CKD stage G3 in 2017–2020. We estimated 3-year risks of rapid progression (defined by a confirmed decline in estimated glomerular filtration rate of ≥5 mL/min/1.73 m2/year), kidney failure, all-cause hospitalization and death. To examine risk markers, we constructed a heat map showing the risk of rapid progression based on predefined markers: albuminuria, sex, diabetes and hypertension/cardiovascular disease. Results Among 133 443 individuals with incident CKD stage G3, the 3-year risk of rapid progression was 14.6% [95% confidence interval (CI) 14.4–14.8]. The 3-year risks of kidney failure, hospitalization and death were 0.3% (95% CI 0.3–0.4), 53.3% (95% CI 53.0–53.6) and 18.1% (95% CI 17.9–18.4), respectively. In the heat map, the 3-year risk of rapid progression ranged from 7% in females without albuminuria, hypertension/cardiovascular disease or diabetes, to 46%–47% in males and females with severe albuminuria, diabetes and hypertension/cardiovascular disease. Conclusion This population-based study shows that CKD stage G3 is associated with considerable morbidity in a community-based setting and underscores the need for optimized prophylactic interventions among such patients. Moreover, our data highlight the potential of using easily accessible markers in routine clinical care to identify individuals who are at high risk of rapid progression.
urology & nephrology,transplantation
What problem does this paper attempt to address?
The study mainly discusses the risk factors and associated consequences of rapid progression in patients with stage 3 chronic kidney disease (CKD). The research was conducted nationwide in Denmark and analyzed data from newly diagnosed stage 3 CKD adults between 2017 and 2020. The study found that approximately 14.6% of patients experienced rapid progression within 3 years, defined as a decline in kidney function of at least 5 mL/min/1.73 m² per year. Furthermore, within 3 years, 0.3% of patients developed kidney failure, 53.3% were hospitalized, and 18.1% died. The study also indicated that the risk increases with the degree of proteinuria, male gender, diabetes, and hypertension/cardiovascular disease. Through a heatmap, it was shown that the risk of rapid progression within 3 years was 7% in females without these risk factors, while it was as high as 46%-47% in males and females with severe proteinuria, diabetes, and hypertension/cardiovascular disease. In conclusion, stage 3 CKD is associated with a significant incidence in the community setting, emphasizing the need for optimized preventive interventions. Additionally, identifying individuals at high risk of rapid progression through easily accessible indicators in routine clinical care has the potential to prevent complications.